Skip to main content
medichelpline
Join Free
Back to Drug Index
General MedicationsORALGeneric

CYCLACILLIN

CYCLACILLIN

Standard Dose
250MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued

Key Takeaways

  • Primary indication: Marketing status: Discontinued
  • Approval overview CYCLACILLIN is listed in Drugs@FDA under application 062895 (ANDA).
  • Marketing status: Discontinued Active ingredient CYCLACILLIN Form and strength TABLET;ORAL - 250MG Sponsor TEVA Submission history Latest submission status date: 1988-05-04 00:00:00.

Structured Monograph

Clinical summary

Approval overview CYCLACILLIN is listed in Drugs@FDA under application 062895 (ANDA). Marketing status: Discontinued Active ingredient CYCLACILLIN Form and strength TABLET;ORAL - 250MG Sponsor TEVA Submission history Latest submission status date: 1988-05-04 00:00:00. Submission type: ORIG.

Monitoring

  • • Review priority: STANDARD
  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.